Business
Aware provides biometric identification software for enrollment, identification, and authentication across government and commercial identity use cases.
Aware's tagged product revenue mix remained biometric-software led, losses widened, cash use worsened, and insiders bought shares.
The read at a glance✓ Audited against SEC data
- Business mix — Biometric identity softwareNote
- Revenue — Product rows led by license and service revenueNote
- Losses — Net loss widened to $5.9MWatch
- Cash — Free cash flow worsened to -$5.6MWatch
- Balance sheet — Equity fell 15.4%Watch
- Insiders — 12 buys / 0 sellsOK
- Accounting — Altman-Z, Beneish-M, and earnings-quality unavailableNote
Where the revenue comes from
Fiscal 2025, as AWARE INC /MA/ reports it. History and quarterly detail are in the app.
- License And Service$12.8M
- Maintenance$8.7M
- Subscription Based Contracts$4.5M
- Service Other$1.3M
- Software As A Service$400K
Leadership changes
From AWARE INC /MA/'s own filings, the day they're filed.
- Mohamed Lazzouni · Chief Technology Officer · departureeff. 2026-03-10
- Ajay Amlani · Chief Executive Officer · appointmenteff. 2025-02-03
- David K. Traverse · Chief Executive Officer · departureeff. 2025-02-03
Latest filings
- 10-Q · Quarterly report2026-07-31
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-21
- DEF 14A · Annual proxy (pay & governance)2026-05-22
- 10-Q · Quarterly report2026-05-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about AWARE INC /MA/, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.